Gabriela Assis de Lemos

Dr. Gabriela Assis de Lemos

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2015 in PeerJ
Verified
Journal Article
Open access
PDF file
YLYury M. Lages
Yury M. Lages
JNJuliana Nascimento
Juliana Nascimento
GLGabriela Assis de Lemos
Gabriela Assis de Lemos
AGAntonio Galina
Antonio Galina
LCLeda R. Castilho
Leda R. Castilho
SRStevens Kastrup Rehen
Stevens Kastrup Rehen
Oxygen concentration should be carefully regulated in all living tissues, beginning at the early embryonic stages. Unbalances in oxygen regulation can lead to cell death and disease. However, to date, few studies have investigated the consequences of variations in oxygen levels for fetal-like cells. Therefore, in the present work, human neural progenitor cells (NPCs) derived from pluripotent stem cells grown in 3% oxygen (v/v) were compared with NPCs cultured in 21% (v/v) oxygen. Low oxygen concentrations altered the mitochondrial content and oxidative functions of the cells, which led to improved ATP production, while reducing generation of reactive oxygen species (ROS). NPCs cultured in both conditions showed no differences in proliferation and glucose metabolism. Furthermore, antioxidant enzymatic activity was not altered in NPCs cultured in 3% oxygen under normal conditions, however, when exposed to external agents known to induce oxidative stress, greater susceptibility to DNA damage was observed. Our findings indicate that the management of oxygen levels should be considered forin vitromodels of neuronal development and drug screening.

8 December 2021 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
GLGabriela Assis de Lemos
Gabriela Assis de Lemos
JMJamila Monteiro
Jamila Monteiro
VOViviane Medeiros Oliveira-Valença
Viviane Medeiros Oliveira-Valença
GMGuilherme A. Melo
Guilherme A. Melo
Ricardo Augusto de Melo ReisRicardo Augusto de Melo Reis
Ricardo Augusto de Melo Reis
AGAntonio Galina
Antonio Galina
Dopamine signaling has numerous roles during brain development. In addition, alterations in dopamine signaling may be also involved in the pathophysiology of psychiatric disorders. Neurodevelopment is modulated in multiple steps by reactive oxygen species (ROS), byproducts of oxidative metabolism which are signaling factors involved in proliferation, differentiation, and migration. Hexokinase (HK), when associated with the mitochondria (mt-HK), is a potent modulator of the generation of mitochondrial ROS in the brain. In this study we investigated whether dopamine could affect both the activity and redox function of mt-HK in human neural progenitor cells (NPCs). We found that dopamine signaling via D1R decreases mt-HK activity and impairs ROS modulation, which is followed by an expressive release of H2O2 and impairment in calcium handling by the mitochondria. Nevertheless, mitochondrial respiration is not affected, suggesting specificity for dopamine on mt-HK function. In neural stem cells (NSCs) derived from iPSCs of schizophrenia patients, mt-HK is unable to decrease mitochondrial ROS, in contrast to NSCs derived from healthy individuals. Our data point to mitochondrial hexokinase as a novel target of dopaminergic signaling, as well as a redox modulator in human neural progenitor cells, which may be relevant to the pathophysiology of neurodevelopmental disorders such as schizophrenia.

18 December 2019 in Journal of Bioenergetics and Biomembranes
Verified
Journal Article
Closed access
PDF file
JMJamila Monteiro
Jamila Monteiro
GLGabriela Assis de Lemos
Gabriela Assis de Lemos
EDEduardo De-Souza-Ferreira
Eduardo De-Souza-Ferreira
AMAdriana M. Marques
Adriana M. Marques
GNGilda Angela Neves
Gilda Angela Neves
AGAntonio Galina
Antonio Galina

23 April 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GLGabriela Assis de Lemos
Gabriela Assis de Lemos
Rayanne Moura do NascimentoRayanne Moura do Nascimento
Rayanne Moura do Nascimento
MAManuela Amaral-do-Nascimento
Manuela Amaral-do-Nascimento
AMAna Carolina Miceli
Ana Carolina Miceli
Tuane C. R. G. VieiraTuane C. R. G. Vieira
Tuane C. R. G. Vieira
Transmissible Spongiform Encephalopathies (TSEs), including prion diseases such as Bovine Spongiform Encephalopathy (Mad Cow Disease) and variant Creutzfeldt–Jakob Disease, pose unique challenges to the scientific and medical communities due to their infectious nature, neurodegenerative effects, and the absence of a cure. Central to the progression of TSEs is the conversion of the normal cellular prion protein (PrPC) into its infectious scrapie form (PrPSc), leading to neurodegeneration through a complex interplay involving the immune system. This review elucidates the current understanding of the immune response in prion diseases, emphasizing the dual role of the immune system in both propagating and mitigating the disease through mechanisms such as glial activation, cytokine release, and blood–brain barrier dynamics. We highlight the differential cytokine profiles associated with various prion strains and stages of disease, pointing towards the potential for cytokines as biomarkers and therapeutic targets. Immunomodulatory strategies are discussed as promising avenues for mitigating neuroinflammation and delaying disease progression. This comprehensive examination of the immune response in TSEs not only advances our understanding of these enigmatic diseases but also sheds light on broader neuroinflammatory processes, offering hope for future therapeutic interventions.

Verified
Journal Article
Open access
PDF file
CACyntia Alves
Cyntia Alves
GLGabriela Assis de Lemos
Gabriela Assis de Lemos
MJMichel Jaworek
Michel Jaworek
GOGuilherme de Oliveira
Guilherme de Oliveira
RWRoland Winter
Roland Winter
Tuane C. R. G. VieiraTuane C. R. G. Vieira
Tuane C. R. G. Vieira
Biomolecular cofactors, including nucleic acids and lipids, promote conversion of the cellular prion protein (PrPC) into pathogenic assemblies (prion scrapie, PrPSc), yet the mechanistic role of specific membrane lipids in the earliest stages remains unclear. Previous work showed that phosphatidic acid (PA) vesicles interact in vitro with murine recombinant PrP (recPrP) and trigger PrP aggregation without additional cofactors. Here, we dissect the PA-driven conversion pathway by monitoring PrP assembly and aggregate stability using spectroscopy and by comparing full-length recPrP with an N-terminally truncated construct. PA vesicles induced aggregation in both PrP constructs with similar efficiency, indicating that PA-mediated conversion does not require residues 23–89. Thermal stability analyses revealed a thermally resilient β-structured state accompanied by temperature-sensitive, partially reversible ThT binding, which we interpret as remodelling of higher-order packing. Time-resolved measurements showed that assembly reached a plateau within the measurement time resolution at all temperatures tested, with no resolvable lag phase. At plateau, the extent of ThT-positive assembly was greatest under conditions of higher bilayer order, while light scattering and secondary-structure content were comparable across temperatures. PrP alone showed no detectable temperature-dependent secondary-structure changes between 10 and 40 °C, consistent with membrane organization contributing to assembly architecture. Together, these results establish PA vesicles as a tractable model for interrogating cofactor-driven early prion aggregation and support membrane lipids and their physical state as modulators of PrP conversion into β-structured assemblies, with implications for mechanistic studies and screening strategies targeting lipid–protein interactions.